Watch SKIN. Know when insiders buy.
One email the day a filing lands. Free.
SKIN
SkinHealth Systems Inc.
0.67
+0.00 +0.76%
USD · close Sep 25
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
45
WATCH · shorts 45
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $86.5MP/E —DIV YIELD —FCF YIELD 24.43%REV TTM $290M −6.5%NET INCOME −$28.4MNET CASH $159.6M52W 0.58 – 2.00SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $72.1M | −7.8% | 68.4% | $3.6M | −$2.7M | −113.5% | -0.02 | $2.7M | $427K | $2.2M | Aug 6 |
| Q1 2026 · Mar 31 | $64.9M | −6.7% | 68.5% | −$1.8M | −$6.6M | — | -0.05 | −$5.6M | $224K | −$5.8M | Aug 6 |
| Q4 2025 · Dec 31derived | $82.4M | −1.3% | 64.4% | $162K | −$8.1M | — | -0.05 | $15.2M | $139K | $15.1M | Mar 12 |
| Q3 2025 · Sep 30 | $70.7M | −10.3% | 64.6% | −$6.2M | −$11M | — | -0.09 | $9.6M | $27K | $9.6M | Nov 6 |
| Q2 2025 · Jun 30 | $78.2M | −13.7% | 62.8% | −$2.7M | $19.7M | +9658.4% | 0.03 | $9.6M | $92K | $9.6M | Aug 6 |
| Q1 2025 · Mar 31 | $69.6M | −14.5% | 69.8% | −$12M | −$10.1M | — | -0.08 | $3M | $45K | $3M | Aug 6 |
| Q4 2024 · Dec 31derived | $83.5M | −13.8% | 62.7% | −$7.2M | −$10.3M | — | -0.05 | $16.5M | $74K | $16.4M | Mar 12 |
| Q3 2024 · Sep 30 | $78.8M | −19.1% | 51.6% | −$21.5M | −$18.3M | — | -0.15 | $10.3M | $4K | $10.3M | Nov 6 |
| Q2 2024 · Jun 30 | $90.6M | — | 45.2% | −$22.1M | $202K | — | -0.10 | $6.2M | $334K | $5.9M | Nov 6 |
| Q1 2024 · Mar 31 | $81.4M | — | 59.4% | −$17M | −$679K | — | -0.10 | −$16.9M | $344K | −$17.2M | Nov 6 |
| Q4 2023 · Dec 31derived | $96.8M | — | 47.2% | −$18.4M | −$9.4M | — | -0.08 | −$5.2M | $28K | −$5.2M | Mar 12 |
| Q3 2023 · Sep 30 | $97.4M | — | -12.9% | −$82.1M | −$73.8M | — | -0.56 | $18M | $174K | $17.8M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $300.8M | 65.3% | −$20.8M | −$9.5M | -3.2% | -0.16 | $37.5M | $303K | $37.2M | $0 | — |
| FY2024 · to Dec 31 | $334.3M | 54.5% | −$67.8M | −$29.1M | -8.7% | -0.36 | $16.1M | $756K | $15.4M | $0 | — |
| FY2023 · to Dec 31 | $398M | 39.0% | −$130.9M | −$100.1M | -25.2% | -0.76 | $21.8M | $3.8M | $17.9M | $30.2M | — |
| FY2022 · to Dec 31 | $365.9M | 68.0% | −$25.8M | $44.2M | 12.1% | -0.23 | −$106.6M | $10.8M | −$117.4M | $160M | — |
| FY2021 · to Dec 31 | $260.1M | 68.6% | −$39.9M | −$378.8M | -145.6% | -3.71 | −$28.4M | $11.2M | −$39.6M | $0 | — |
| FY2020 · to Dec 31 | $119.1M | 56.4% | −$17.2M | −$29.2M | -24.5% | -0.85 | −$12.4M | $3.5M | −$15.9M | $154K | — |
Every number comes from SkinHealth Systems Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.